Andreas Harstrick
Chief Executive Officer at AFFIMED N.V.
Net worth: 371 085 $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| William Burns | M | 76 | 7 years | |
| Harry Welten | M | 59 | 4 years | |
| Ulrich Grau | M | 75 | 9 years | |
| Thomas O. Hecht | M | 73 | 17 years | |
| Bernhard R. M. Ehmer | M | 69 | 8 years | |
| Uta Kemmerich-Keil | F | 58 | 3 years | |
| Mary Beth Sandin | F | - | - | |
| Constanze Ulmer-Eilfort | M | 62 | 1 years | |
| Gino Santini | M | 66 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 16 years |
| William Chin | M | 76 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 16 years |
| Annalisa Jenkins | M | 58 | 4 years | |
| Mathieu Simon | M | 68 | 6 years | |
| Susanne Hering | F | - | 9 years | |
| Wolfgang Fischer | M | 60 | 7 years | |
| Alexander Fudukidis | M | - | 4 years | |
| Denise Mueller | F | 55 | 8 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Christian Zahnd | M | 49 | 12 years | |
| Adolf Hoess | M | 62 | 14 years | |
| Ferdinand Verdonck | M | 81 | 7 years | |
| Joseph I. DePinto | M | 57 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 4 years |
| Jörg Reinbrecht | M | 67 |
University of Hannover
| 6 years |
| John E. Celentano | M | 64 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | - |
| Bernd Reckmann | M | 68 |
University of Hannover
| 8 years |
| Jörg Lauenroth-Mago | M | 68 |
University of Hannover
| 7 years |
| Christine Cvijic | F | 46 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 3 years |
| Daniel O'Connor | M | 59 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 6 years |
| Berndt A. E. Modig | M | 65 | 6 years | |
| John Johnson | M | 66 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 1 years |
| Elke Lossin | M | 59 |
University of Hannover
| 9 years |
| Jennifer Simpson | M | 55 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 4 years |
| Eric Rowinsky | M | 67 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 4 years |
| Angus Smith | M | 41 | 3 years | |
| Gregory Mayes | M | 55 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 6 years |
| Ziaedin Chahabadi | M | 73 |
University of Hannover
| 3 years |
| Karsten Karl-Georg Liebing | M | 58 |
University of Hannover
| 4 years |
| Peter Krippner | M | - |
University of Hannover
| 4 years |
| QI Bo | M | - |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 6 years |
| Klaus-Dieter Gerdsmeyer | M | 63 |
University of Hannover
| 4 years |
| Andreas Höch | M | - |
University of Hannover
| 6 years |
| Edeltraud Glänzer | M | 68 |
University of Hannover
| 7 years |
| Glenn Whaley | M | 56 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 6 years |
| Arndt Justus Georg Schottelius | M | 58 | 4 years | |
| Klaus Schroeter | M | 65 |
University of Hannover
| 5 years |
| Hans Richard Schmitz | M | 67 |
University of Hannover
| 6 years |
| Arnold Picot | M | 79 |
University of Hannover
| 8 years |
| Helmut Limberg | M | - |
University of Hannover
| 3 years |
| Weichang Zhou | M | 59 |
University of Hannover
| 3 years |
| Gwen A. Fyfe | M | 72 | 4 years | |
| Ramona M. Lloyd | M | - |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 1 years |
| Laura Mattlin | F | - |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 1 years |
| Peter Alfred Kurt Haase | M | - |
University of Hannover
| 4 years |
| Ludger Overmeyer | M | 60 |
University of Hannover
| 4 years |
| Elizabeth Yamashita | F | - |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 5 years |
| Nicolas Leupin | M | 50 | 4 years | |
| Kenneth Zuerblis | M | 64 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 1 years |
| Rainer Martens | M | 63 |
University of Hannover
| 5 years |
| Bryce D. Carmine | M | 72 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | - |
| Charles Woler | M | 74 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 2 years |
| Steven Paul | M | 73 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | - |
| Michael P. Bailey | M | 58 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 9 years |
| David Sidransky | M | 64 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 4 years |
| Andrew Powell | M | 66 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 1 years |
| Derica Rice | M | 59 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | - |
| Carl Icahn | M | 88 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 2 years |
| Robert L. Crotty | M | 50 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 3 years |
| Alexander Denner | M | 54 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 2 years |
| Jeffrey H. Buchalter | M | 67 | 2 years | |
| Jörn Aldag | M | 65 | 11 years | |
| Gregory D. Plowman | M | - |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | - |
| Andrew Bonfield | M | 61 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 1 years |
| Heinz-Jürgen Bertram | M | 65 |
University of Hannover
| 3 years |
| Thomas F. Deuel | M | 89 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 1 years |
| Jørgen Søberg Petersen | M | - |
Merck Serono Ltd.
 Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Merck Serono Ltd. provides research and development services and manufactures medicinal drugs. The company is headquartered in Middlesex, the United Kingdom. | 5 years |
| Helmut Thomas | M | 72 |
University of Hannover
| 3 years |
| Peter S. Liebert | M | 88 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 2 years |
| Otto Müller | M | 67 |
University of Hannover
| 3 years |
| Jules Haimovitz | M | 73 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 1 years |
| Rémi Delansorne | M | 64 |
Merck Serono Ltd.
Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Merck Serono Ltd. provides research and development services and manufactures medicinal drugs. The company is headquartered in Middlesex, the United Kingdom. | - |
| Volker Pape | M | 69 |
University of Hannover
| 4 years |
| Martin Heuser | M | 67 |
University of Hannover
| 6 years |
| Richard Mulligan | M | 69 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 2 years |
| Rolf Haferkamp | M | 60 |
University of Hannover
| 6 years |
| Pamela A. Trail | M | 68 | 1 years | |
| Margaret Dalesandro | M | 77 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 7 years |
| John Sørensen Haurum | M | 61 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 2 years |
| Julien Gander | M | 45 | 6 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Germany | 42 | 48.84% |
| United States | 34 | 39.53% |
| Switzerland | 8 | 9.30% |
| United Kingdom | 2 | 2.33% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Andreas Harstrick
- Personal Network
